Review of the etiology and treatment of premenstrual syndrome.
Premenstrual syndrome (PMS) is a diagnostic enigma that causes significant morbidity in many woman. Numerous theories have been proposed in an attempt to explain the varied symptoms that occur cyclically in women with PMS. Suggested etiologic theories of PMS include psychological abnormalities, nutritional deficiencies, aberrations in the renin-angiotensin-aldosterone axis, altered prostaglandin activity, hormonal imbalances, and changes in endogenous opioid peptide activity. Because of the lack of standardized diagnostic criteria, clinical drug trials for PMS have been severely compromised. For every proposed cause of PMS, there exists a drug or drug class that has been investigated for treatment of the associated symptoms. Many clinical studies are uncontrolled, a significant deficiency in study design for a disorder that is associated with a high placebo response rate. At the present time, no definitive treatment for PMS exists and therapy must be individualized according to clinical response. This review article defines PMS, describes one of the current approaches to the diagnostic work-up, discusses the proposed etiologies of PMS, and reviews the various proposed treatment modalities.
D001971:Bromocriptine / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D010906:Pituitary Hormone-Releasing Hormones / Q000627:therapeutic use; D010936:Plant Extracts / Q000627:therapeutic use; D011293:Premenstrual Syndrome / Q000175:diagnosis / Q000178:diet therapy / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D011374:Progesterone / Q000627:therapeutic use; D009626:Terminology as Topic; D014815:Vitamins / Q000627:therapeutic use
D004232:Diuretics; D010906:Pituitary Hormone-Releasing Hormones; D010936:Plant Extracts; D014815:Vitamins; D001971:Bromocriptine; D011374:Progesterone; D008094:Lithium